Back to the list

The 13th Meeting of the Israel Controlled Release Society 2023

The Israeli Chapter of the Controlled Release Society (ICRS) was founded in 1996 with the mission to enhance the interactions between Academia and Industry in Israel. This mission is achieved in the annual meetings of the society in which the members meet and exchange ideas and in which collaborations are established.

For more information, please visit the  ICRS 2023 Website.

The Phospholipid Research Center Heidelberg will provide financial support for this conference.

Invited Speakters

  • Prof. Yvonne Perrie, Head Of Institute, Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow
  • Prof. Ofra Benny, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel
  • Prof. Emeritus Yechezkel (Chezy) Barenholz, Professor of Biochemistry and Head of the Liposome and Membrane Research Lab, Hebrew University-Hadassah Medical School of Jerusalem at Hebrew University of Jerusalem
  • Prof. Stefaan de Smedt, Director of Ghent Research Group on Nanomedicines, Director of Laboratory of General Biochemistry and Physical Pharmacy, Editor-in-chief of the Journal of Controlled Release, Ghent University, Belgium
  • Prof. Ronit Satchi Fainaro, Head, Cancer Research and Nanomedicine Laboratory, Director, Cancer Biology Research Center Faculty of Medicine Tel Aviv University, Israel
  • Dr. Assaf Zinger, Bioinspired Nano Engineering &Translational Therapeutics Lab, Technion - Israel Institute of Technology, Haifa, Israel
  • Prof. Boaz Mizrahi, Faculty of Biotechnology and Food Engineering, Technion - Israel Institute of Technology, Haifa, Israel
  • Dr. Aharon Azagury, The Department of Chemical Engineering and Biotechnology, Ariel University, Israel
  • Prof. Alejandro Sosnik, Department of Materials Science and Engineering, Technion - Israel Institute of Technology, Haifa, Israel
  • Prof. Rachela Popovtzer, Faculty of Engineering and the Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Israel
  • Prof. Zvi Yaari, The School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Israel
  • Prof. Joseph Kost, Department of Chemical Engineering, Ben-Gurion University of the Negev, Israel
  • Prof. Tal Dvir, Director, Laboratory for Tissue Engineering and Regenerative Medicine, Director, Tel Aviv University Center for Nanoscience & Nanotechnology, Tel Aviv University, Israel
  • Prof. Ayelet David, Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Israel
  • Prof. Yosi Shamay, Head of Cancer Nanomedicine and Nanoinformatics Lab, Biomedical Engineering, Technion - Israel Institute of Technology, Haifa, Israel
  • Prof. Itai Benhar, Director of the Tel Aviv University Center for Combatting Pandemics, Head of the Antibody Engineering Lab
    Tel Aviv University
  • Dr. Luai Khoury, Department of Materials Science and Engineering
    Technion, Israel
  • Prof. Shady Farah, The Laboratory for Advanced Functional/Medicinal Polymers & Smart Drug Delivery Technologies, The Wolfson Faculty of Chemical Engineering, Technion, Israel
  • Dr. Andreas Wagner, Polymun Scientific, Immunbiologische Forschung GmbH, Austria
  • Prof. Dmitri Simberg, Associate Professor, Translational Bio-Nanosciences Laboratory, Department of Pharmaceutical Sciences, University of Colorado, USA
  • Prof. Helena Florindo, University of Lisbon, Faculty of Pharmacy, Portugal
  • Prof. Maria J. Vicent, Polymer Therapeutics Lab, Prince Felipe Research Center (CIPF), Valencia, Spain
  • Dr. Simon Drescher, Phospholipid Research Center, Heidelberg, Germany
  • Prof. Helder A. Santos, Department of Biomedical Engineering, University Medical Center Groningen, University of Groningen, The Netherlands
  • Prof. Roey Amir, Associate Professor, School of Chemistry, Academic Head of the ADAMA Center for Novel Delivery Systems in Crop Protection, Tel Aviv University, Israel
  • Dr. Aiman Abu Ammar, Department of Pharmaceutical Engineering, Azrieli College of Engineering Jerusalem, Israel
  • Dr. Ranit Kedmi, The department of Systems Immunology, The Weizmann Institute for Science, Israel